There has still been no reckoning for the five long months it took for the authorities to warn the public about myocarditis from Covid vaccines, nor for falsely claiming it was only "mild" when they did, says Dr Ros Jones.
The post There Has Been No Reckoning for the Five Months it Took to Warn the Public About Myocarditis From Covid Vaccines appeared first on The Daily Sceptic.
New mRNA jabs could change how vaccines chase viruses.
Independent advisors for the Food and Drug Administration on Friday voted 9–0 in support of approving Moderna's seasonal mRNA flu vaccine, which a Trump appointee at the agency initially tried to block from even being reviewed.
In an all-day meeting, members of the FDA's advisory committee—known as VRBPAC for Vaccines and Related Biological Products Advisory Committee—pored over data and presentations on the vaccine, which is dubbed mRNA-1010 and branded as mFlusiva. The presentations included a review from FDA scientists, which was supportive of the vaccine.
Data from a Phase 3 trial including over 40,000 adults age 50 and older found the mRNA vaccine was around 27 percent more effective against seasonal flu than a standard flu shot. A smaller Phase 3 trial, involving data from nearly 3,000 people age 65 years and older, showed the shot produces stronger immune responses than a high-dose flu vaccine, which is recommended for this age group. The safety profile of the vaccine was also generally good.
© DeFodi Images
Login